colforsin has been researched along with Adrenocortical Carcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, KEM; Frøysa, HG; Goksøyr, A; Karlsen, OA; Kellmann, R; Mellgren, G; Ropstad, E; Sagen, JV; Verhaegen, S | 1 |
| Auernhammer, CJ; Beuschlein, F; Johnsen, IK; Kappler, R | 1 |
| Assie, G; Bertherat, J; Cazabat, L; Fierrard, H; Groussin, L; Martinez, A; Perlemoine, K; Ragazzon, B; Rizk-Rabin, M | 1 |
| Ehrlund, A; Gustafsson, JÅ; Jonsson, P; Treuter, E; Vedin, LL; Williams, C | 1 |
| Bornstein, SR; Haase, M; Malendowicz, LK; Scherbaum, WA; Schott, M; Willenberg, HS | 1 |
| Cobb, VJ; Mason, JI; Walker, SW; Williams, BC | 1 |
6 other study(ies) available for colforsin and Adrenocortical Carcinoma
| Article | Year |
|---|---|
LC-MS/MS based profiling and dynamic modelling of the steroidogenesis pathway in adrenocarcinoma H295R cells.
Topics: Adenylyl Cyclases; Adrenocortical Carcinoma; Cell Line, Tumor; Chromatography, Liquid; Colforsin; Endocrine Disruptors; High-Throughput Screening Assays; Humans; Metabolome; Steroids; Tandem Mass Spectrometry | 2018 |
Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Blotting, Western; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 5; Bone Morphogenetic Protein Receptors; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Dose-Response Relationship, Drug; Down-Regulation; GATA6 Transcription Factor; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Phosphorylation; Proto-Oncogene Proteins c-akt; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Steroid 17-alpha-Hydroxylase; Time Factors; Tretinoin; Tumor Cells, Cultured | 2009 |
Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Apoptosis; Cell Line, Tumor; Colforsin; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Cyclic AMP-Dependent Protein Kinases; Gene Silencing; Humans; Male; Mice; RNA, Messenger; RNA, Small Interfering; Smad3 Protein; Transcription, Genetic; Transfection; Transforming Growth Factor beta | 2009 |
Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells.
Topics: Adrenal Cortex; Adrenocortical Carcinoma; beta Catenin; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Cell Line, Tumor; Colforsin; Computational Biology; Gene Expression Regulation; Gene Knockdown Techniques; Gonadal Steroid Hormones; Humans; Microarray Analysis; Polymerase Chain Reaction; RNA, Small Interfering; Steroidogenic Factor 1; Transforming Growth Factor beta; Ubiquitin-Protein Ligases; Wnt Signaling Pathway | 2012 |
CITED2 is expressed in human adrenocortical cells and regulated by basic fibroblast growth factor.
Topics: Adrenal Cortex; Adrenocortical Carcinoma; Adrenocorticotropic Hormone; Adult; Cell Line, Tumor; Cells, Cultured; Colforsin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryonic Development; Fibroblast Growth Factor 2; Gene Expression Regulation; Humans; Immunohistochemistry; Microscopy, Fluorescence; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trans-Activators; Transfection | 2007 |
Direct stimulation of cortisol secretion from the human NCI H295 adrenocortical cell line by vasoactive intestinal polypeptide.
Topics: Adrenal Cortex Neoplasms; Adrenergic beta-Antagonists; Adrenocortical Carcinoma; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Propranolol; Radioimmunoassay; Stimulation, Chemical; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1997 |